1. Home
  2. Proposition 65
  3. Meeting Synopsis and Slide Presentations from t...

Meeting Synopsis and Slide Presentations from the Carcinogen Identification Committee Meeting Held on November 2, 2017

Request Meeting Presentations

A meeting of the Proposition 65[1] Carcinogen Identification Committee (CIC)[2] was held on November 2, 2017, at the California Environmental Protection Agency headquarters building in Sacramento, California.  The committee considered coumarin for listing as known to the state to cause cancer.

A summary of the meeting is provided below.  

SUMMARY OF THE LISTING DECISION FOR COUMARIN

Coumarin will not be added to the Proposition 65 list of chemicals known to the state to cause cancer.  

In voting on whether coumarin “has been clearly shown through scientifically valid testing according to generally accepted principles to cause cancer”, the seven CIC members in attendance made the following determination: Four members voted yes, 2 voted no, and 1 abstained. Five “yes” votes were needed to add coumarin to the list.

UPDATE OF THE TITLE 27, CAL. CODE OF REGULATIONS, SECTION 27000 LIST OF CHEMICALS WHICH HAVE NOT BEEN ADEQUATELY TESTED AS REQUIRED

The CIC voted unanimously in favor of updating the Section 27000 list of Chemicals That Have Not Been Adequately Tested As Required, based on recommendations included in the OEHHA staff report and information provided by the California Department of Pesticide Regulation and the US EPA.

STAFF UPDATES
The Committee was provided with updates on activities related to chemical listings, adoption of Safe Harbor Levels, Proposition 65 litigation, and other regulatory activities.

 

Footnotes and References

[1] The Safe Drinking Water and Toxics Enforcement Act of 1986, codified at Health and Safety Code section 25249.5 et seq.

[2] Health and Safety Code section 25249.8(b) and Title 27, Cal. Code of Regs., section 25302 et seq.

 

Downloads

    Meeting Announcements/Information

  • Carcinogen Identification Committee Meeting Scheduled for November 2, 2017

    Coumarin will be considered for possible listing by the CIC at a public meeting. The meeting will be held in the Sierra Hearing Room at the CalEPA Headquarters building, 1001 I Street, Sacramento, California. This notice also marks the beginning of a 45-day public comment period on this document.

    Thu, 11/02/2017 to Fri, 11/03/2017